Jeremy Adler, MD, MSc
Clinical Professor of Pediatrics and Interim Section Head
CHEAR Center
Pediatric Gastroenterology

Available to mentor

Jeremy Adler, MD, MSc
Clinical Professor
  • About
  • Qualifications
  • Center Memberships
  • Recent Publications
  • About

    Jeremy Adler, M.D., M.Sc. is a Clinical Professor in the Division of Pediatric Gastroenterology at the University of Michigan and serves as the Interim Director of the Susan B. Meister Child Health Evaluation and Research (CHEAR) Center. Dr. Adler earned his M.D. degree at the University of South Florida College of Medicine. He completed his residency in pediatrics at Boston City Hospital and Boston Medical Center in 1997. He then practiced academic general pediatrics in New York for several years before moving to Michigan to train in pediatric gastroenterology at the University of Michigan. He then earned a Master of Science in Health and Health Care Research through in the Horace H. Rackham School of Graduate Studies at the University of Michigan, and had further training in the Advanced Improvement Methods program at Cincinnati Children’s Hospital. Dr. Adler joined the pediatric gastroenterology faculty at the University of Michigan in 2008.

    Dr. Adler's clinical and research interest is in the care of children and adolescents with Crohn's disease and ulcerative colitis (inflammatory bowel disease or IBD). His research focus is on improving short and long-term outcomes and health related quality of life for children with IBD. He has been working on developing evidence-based strategies for preventing disease related complications such as fistulas and pouchitis, and to mitigate disparities among children with IBD.

    Dr. Adler is an NIH-funded researcher whose scientific research has been featured in the American Gastroenterology Association's headline news, on the cover of the journal Inflammatory Bowel Diseases, and in the Innovations in Health Care section of the Wall Street Journal. Dr. Adler is a leader in the field of pediatric IBD, and has served as consultant to the US Food and Drug Administration, and his work on prevention of disease complications and on developing methods for evaluating endoscopic findings has been used in national and international policies and guidelines on treating children and adults with IBD. Dr. Adler also serves as the Director of Research and Quality Improvement in Pediatric Gastroenterology, and as the Director of the Pediatric IBD Program at C.S. Mott Children’s Hospital at Michigan Medicine.

    Qualifications
    • Adaptive Leadership
      University of Michigan, United states, 2024
    • Advanced Improvement Methods (AIM), Center for Health Care Quality
      Cincinnati Children's Hospital Medical Center, Cincinnati, 2015
    • Linkage Leadership Academy
      University of Michigan, Ann Arbor, 2015
    • Pediatric gastroenterology Fellowship
      C. S. Mott Children's Hospital, Ann Arbor, 2008
    • Pediatric Residency
      Boston Medical Center, Boston, 1997
    • MSc
      Horace H. Rackham School of Graduate Studies, University of Michigan, Ann Arbor, 2009
    • MD
      University of South Florida College of Medicine, 4202 E Fowler Ave, 1994
    • BS
      University of Florida, Gainesville, 1990
    Center Memberships
    • Center Member
      Institute for Healthcare Policy and Innovation
    Recent Publications See All Publications
    • Journal Article
      National perspectives of barriers by insurance and pharmacy benefit managers in pediatric inflammatory bowel disease
      Constant BD, Adler J, Gold BD, Dotson J, Lightdale JR, Scott F, Saeed S, Kim S, Moses J, de Zoeten EF, Mirea L, Ritchey A, Pasternak B. JPGN Reports, DOI:10.1002/jpr3.70004
    • Journal Article
      Reducing Disparities in Access to Kidney Transplantation Regional Study: A Randomized Trial in the Southeastern United States.
      Patzer RE, Buford J, Urbanski M, McPherson L, Paul S, Di M, Harding JL, Katz-Greenberg G, Rossi A, Anand PM, Reeves-Daniel A, Jones H, Mulloy L, Pastan SO, Southeastern Kidney Transplant Coalition . Clin J Am Soc Nephrol, 2024 Dec 13; 20 (2): 256 - 266. DOI:10.2215/CJN.0000000586
      PMID: 39671258
    • Journal Article
      Circulating and Magnetic Resonance Imaging Biomarkers of Intestinal Fibrosis in Small Bowel Crohn's Disease.
      Dillman JR, Tkach JA, Fletcher JG, Bruining DH, Lu A, Kugathasan S, Alazraki AL, Knight-Scott J, Stidham RW, Adler J, Minar P, Trapnell BC, Bonkowski EL, Jurrell H, Lopez-Nunez O, Collins MH, Swanson SD, Fei L, Qian L, Towbin AJ, Kocaoglu M, Anton CG, Imbus RA, Dudley JA, Denson LA. Inflamm Bowel Dis, 2025 Jan 24; DOI:10.1093/ibd/izae319
      PMID: 39853252
    • Journal Article
      P0781 Perianal lesions present at paediatric Crohn’s disease diagnosis require early treatment with tumour necrosis factor antagonist to reduce high risk of perianal fistulising complications: a post-hoc analysis of a prospective, multicentre study
      Adler J, Gadepalli S, group BS. Journal of Crohn's and Colitis, 2025 Jan 22; 19 (Supplement_1): i1507 - i1508. DOI:10.1093/ecco-jcc/jjae190.0955
    • Journal Article
      P1057 Early use of tumour necrosis factor antagonist for treatment of paediatric Crohn’s disease decreases perianal fistula development: a post-hoc analysis of a prospective, multicentre study
      Gadepalli S, Adler J, group BS. Journal of Crohn's and Colitis, 2025 Jan 22; 19 (Supplement_1): i1948 - i1949. DOI:10.1093/ecco-jcc/jjae190.1231
    • Journal Article
      Update on Treating Painful Diabetic Peripheral Neuropathy: A Review of Current US Guidelines with a Focus on the Most Recently Approved Management Options.
      Mallick-Searle T, Adler JA. J Pain Res, 2024 17: 1005 - 1028. DOI:10.2147/JPR.S442595
      PMID: 38505500
    • Journal Article
      Development and Validation of the Narrative Identity Self-Evaluation Scale (NISE).
      Lind M, R Cowan H, Adler JM, McAdams DP. J Pers Assess, 2024 Nov 15; 1 - 14. DOI:10.1080/00223891.2024.2425663
      PMID: 39546387
    • Journal Article
      Beyond "post," "traumatic," "growth," and prediction in research on posttraumatic growth.
      Adler JM, Schwaba T. Am Psychol, 2024 Nov; 79 (8): 1227 - 1240. DOI:10.1037/amp0001398
      PMID: 39531718
    Featured News & Stories Joanne standing in front of a research poster she created
    Points of Blue
    Joanne Constantin, Postdoc: Bridging the fields of public health and medicine
    In this interview, Joanne answers questions about her work as a postdoctoral fellow in Health & Healthcare Research and the real-world impact it’s having.
    shot in arm patient rolled up sleeve
    Health Lab
    Why anti-TNF drugs don’t work for some kids with Crohn's disease
    Research from Michigan Medicine investigated possible genetic factors for drug efficacy for children with Crohn’s disease. 
    syringes three in a row with one with a shot going into it on a light teal background
    Health Lab
    TNF inhibitors prevent complications in kids with Crohn’s disease, recommended as first-line therapies
    Early treatment of pediatric Crohn’s disease with anti-tumor necrosis factor medications can substantially reduce the risk of perianal fistulas in Crohn’s disease. Michigan Medicine researchers confirmed this finding using prospective data.